Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Wilson

Showing results (541-550 of 546) with videos related to

Pageof 55
Sort By:
You have reached the last page of results.This site can display upto 546 results.
Trials|April 15, 2022
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)Seonaidh Cotton, Graham Devereux, Hassan Abbas, et al.
Respiratory Research|June 28, 2018
Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology StudyCarl M Philpott, Sally Erskine, Claire Hopkins, et al.
Nature Communications|May 15, 2025
Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 studyDanielle K Sohai, Michael D Keller, Patrick J Hanley, et al.
Journal of the American College of Cardiology|July 24, 2024
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary PreventionJingqin Wu, Corey Giles, Aleksandar Dakic, et al.
Journal of the American College of Cardiology|September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art ReviewGemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trialP G Corrie, A Marshall, P D Nathan, et al.
Pageof 55

Showing results (541-550 of 546) with videos related to

Sort By:
Pageof 55
You have reached the last page of results.This site can display upto 546 results.
Trials|April 15, 2022
Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)Seonaidh Cotton, Graham Devereux, Hassan Abbas, et al.
Respiratory Research|June 28, 2018
Prevalence of asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology StudyCarl M Philpott, Sally Erskine, Claire Hopkins, et al.
Nature Communications|May 15, 2025
Autologous HIV-specific T cell therapy targeting conserved epitopes is well-tolerated in six adults with HIV: an open-label, single-arm phase 1 studyDanielle K Sohai, Michael D Keller, Patrick J Hanley, et al.
Journal of the American College of Cardiology|July 24, 2024
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary PreventionJingqin Wu, Corey Giles, Aleksandar Dakic, et al.
Journal of the American College of Cardiology|September 20, 2023
Clinical Pathway for Coronary Atherosclerosis in Patients Without Conventional Modifiable Risk Factors: JACC State-of-the-Art ReviewGemma A Figtree, Stephen T Vernon, Jason A Harmer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trialP G Corrie, A Marshall, P D Nathan, et al.
Pageof 55